Showing results (11-20 of 469) with videos related to

Sort By:
Pageof 47
Breast Cancer Research and Treatment|June 25, 2022
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapyTal Sella, Olga Kantor, Anna Weiss, et al.
Journal of the American College of Surgeons|August 11, 2020
Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast CancerChristina A Minami, Olga Kantor, Anna Weiss, et al.
Journal of Surgical Oncology|February 22, 2011
Selecting local therapy in the young breast cancer patientTari A King
Annals of Surgical Oncology|November 22, 2025
Surgeon Perspectives on Axillary Management Following Neoadjuvant Endocrine Therapy: Results from a Qualitative Substudy of the PELOPS TrialAnna Weiss, Anna Revette, Brett Nava-Coulter, et al.
Annals of Surgical Oncology|December 5, 2024
Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TADAlison Laws, Saskia Leonard, Julie Vincuilla, et al.
Annals of Surgical Oncology|September 2, 2020
Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast CancerOlga Kantor, Melia Wakeman, Anna Weiss, et al.
JAMA Oncology|September 9, 2021
Neoadjuvant Endocrine Therapy in Clinical Practice: A ReviewTal Sella, Anna Weiss, Elizabeth A Mittendorf, et al.
Pageof 47